Clinical Trials

The purpose of this study is to facilitate quality improvement and description of treatment with this novel dialysis device dedicated to the treatment of infants with AKI or fluid overload.

This study will assess the safety of a new biologic drug, RBX2660 (microbiota suspension) as a treatment for recurrent Clostridium difficile-associated diarrhea (CDAD), which is the primary symptom of recurrent Clostridium difficile infection. All eligible subjects will receive RBX2660.

The purpose of this study is to assess the safety and effectiveness of Bronchial Rheoplasty for the treatment of the symptoms of chronic bronchitis in adult COPD patients with moderate to severe chronic bronchitis.

This study is utilizing the Mayo Clinic Cures at Home participation services. For questions regarding home research services in this study please reach out to curesathome@mayo.edu.

The purpose of this study is to investigate facial pain improvement with twice-daily use of a novel device combing acoustic vibration with oscillating expiratory pressure compared with a sham device in male and female participants > 18 years of age with sinus pain/headache lacking objective evidence of sinonasal inflammation.

The purpose of this study is to evaluate GDA-201, an allogeneic cryopreserved NK cell therapy derived from donor peripheral blood, in combination with rituximab, monoclonal anti-CD20 antibody, for patients with relapsed or refractory B Cell non-Hodgkin lymphoma (NHL).